INmune Bio Inc (INMB)
6.24
+0.20
(+3.31%)
USD |
NASDAQ |
Nov 04, 16:00
6.21
-0.03
(-0.48%)
After-Hours: 20:00
INmune Bio Price to Book Value: 3.577 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.577 |
| November 01, 2024 | 3.463 |
| October 31, 2024 | 3.354 |
| October 30, 2024 | 3.411 |
| October 29, 2024 | 3.612 |
| October 28, 2024 | 3.534 |
| October 25, 2024 | 3.107 |
| October 24, 2024 | 2.993 |
| October 23, 2024 | 2.866 |
| October 22, 2024 | 2.947 |
| October 21, 2024 | 2.970 |
| October 18, 2024 | 2.930 |
| October 17, 2024 | 2.866 |
| October 16, 2024 | 2.987 |
| October 15, 2024 | 2.769 |
| October 14, 2024 | 2.912 |
| October 11, 2024 | 2.947 |
| October 10, 2024 | 2.878 |
| October 09, 2024 | 2.947 |
| October 08, 2024 | 3.044 |
| October 07, 2024 | 3.004 |
| October 04, 2024 | 3.130 |
| October 03, 2024 | 3.038 |
| October 02, 2024 | 3.044 |
| October 01, 2024 | 3.159 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.090 |
| September 27, 2024 | 3.121 |
| September 26, 2024 | 2.966 |
| September 25, 2024 | 2.906 |
| September 24, 2024 | 3.062 |
| September 23, 2024 | 3.086 |
| September 20, 2024 | 3.121 |
| September 19, 2024 | 3.187 |
| September 18, 2024 | 3.103 |
| September 17, 2024 | 3.319 |
| September 16, 2024 | 3.22 |
| September 13, 2024 | 2.920 |
| September 12, 2024 | 3.418 |
| September 11, 2024 | 3.332 |
| September 10, 2024 | 3.201 |
| September 09, 2024 | 3.318 |
| September 06, 2024 | 3.137 |
| September 05, 2024 | 3.201 |
| September 04, 2024 | 3.281 |
| September 03, 2024 | 3.281 |
| August 30, 2024 | 3.532 |
| August 29, 2024 | 3.660 |
| August 28, 2024 | 3.644 |
| August 27, 2024 | 3.767 |
| August 26, 2024 | 3.761 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.006
Minimum
Mar 18 2020
11.49
Maximum
Sep 07 2021
3.596
Average
2.807
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.082 |
| Theriva Biologics Inc | 0.0803 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 899.58 |
| PEG Ratio | -0.1126 |
| Price | 6.24 |
| Earnings Yield | -34.94% |
| Market Cap | 138.36M |
| PEGY Ratio | -0.1126 |